Skip to main content
Protagonist Therapeutics, Inc logo

Protagonist Therapeutics, Inc — Investor Relations & Filings

Ticker · PTGX ISIN · US74366E1029 US Manufacturing
Filings indexed 641 across all filing types
Latest filing 2022-02-10 Major Shareholding Noti…
Country US United States of America
Listing US PTGX

About Protagonist Therapeutics, Inc

https://www.protagonist-inc.com/

Protagonist Therapeutics, Inc. is a clinical-stage biopharmaceutical company that specializes in the discovery and development of peptide-based new chemical entities. The company utilizes its proprietary technology platform to engineer novel oral and injectable peptide therapeutics. Its development pipeline is focused on creating treatments for rare and prevalent diseases, particularly in the areas of hematology and gastroenterology, addressing significant unmet medical needs.

Recent filings

Filing Released Lang Actions
Major Shareholding Notification 2022
Major Shareholding Notification
2022-02-10 English
Major Shareholding Notification 2022
Major Shareholding Notification
2022-02-09 English
Major Shareholding Notification 2022
Major Shareholding Notification
2022-02-03 English
OWNERSHIP DOCUMENT
Director's Dealing
2021-12-23 English
10-Q
Interim / Quarterly Report Q3 2021
2021-11-03 English
FORM 8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated November 3, 2021, reporting the financial results for the quarter ended September 30, 2021. It includes a press release titled 'Protagonist Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Update' as an exhibit. The document is relatively short (4276 characters) and primarily serves to announce the earnings release and provide the press release as an exhibit. It does not contain the full financial statements or detailed analysis itself but references the press release. According to the classification rules, such a document is best classified as an Earnings Release (ER) since it is the initial announcement of quarterly financial results with key highlights, not a full interim report or annual report. The presence of the press release and the nature of the Form 8-K filing support this classification.
2021-11-03 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.